METHODS	Patients 18 years or older were randomly assigned to receive irinotecan 60 mg/m2 and docetaxel 35 mg/m2 , or irinotecan 100 mg/m2 and gemcitabine 1,000 mg/m2 , with or without CBX 400 mg twice daily , for four cycles .\